We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Swoopos is a mobile point of sale system, which brings together innovative software and hardware, cloud reporting and data analytics, mobile and ecommerce ordering and beacon marketing technology for retail, hospitality and stadiums.  Swoops have already built long term relationships with leading brands and are now looking to expand throughout the UK and beyond.
days to go: Expired investment: £64,480
Pedal Me uses high-tech cargo bikes, trailers and trained riders to provide delivery & taxi services when needed. The company offers a solution that will out-perform motors in car-centric cities as bike-friendly measures like bike lanes are introduced. As of now, the company has 32 bikes and 45 staff in total. It has witnessed a strong MoM growth (19% on avg). The trips provided by Pedal Me has negligible carbon footprint in comparison with vans, taxis or electric vehicles. With the funds, the company will improve the technology, maintain speed with demand, develop the staff and balance the process.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £421,330
Swing has pioneered an IoT-connected micro-gym, the Swing Box, equipped with integrated free weights suitable for outdoor use. This innovative gym solution includes adjustable backrests and various dumbbells and kettlebells, catering to users of all fitness levels. Users can conveniently locate, reserve, and unlock the Swing Box using any smartphone, aiming to combat physical inactivity, which contributes to a significant number of deaths and costs the UK £7.4 billion annually. Swing's solution addresses the barriers of affordability, accessibility, and time in exercise by providing on-demand, free-access outdoor micro-gyms in communal parks and green spaces. With over 90% of UK residents within a 10-minute walk of public parks and only 32% meeting NHS guidelines for muscle-strength activity, Swing aims to lease these boxes to grant public access with leaseholders paying an annual fee of £2500 per box, covering maintenance and operations.
days to go: Expired investment: £287,590
SRSLY Low Carb, an award-winning health food brand, specializes in high protein, low carb products to make healthy eating both convenient and delicious. They've already played a significant role in 4.5 million meals and generated over £6 million in revenue, boasting an impressive 79% repeat order rate and a 35% subscription rate. With a recent NHS England contract and the first US retail order secured, SRSLY is poised to expand into local and international retail markets with the ambition of becoming a global leader in the field. They've demonstrated market fit with customers reporting benefits like longer satiation for weight loss and better blood sugar control for those with diabetes. As 70% of adults seek healthier food options, SRSLY sees abundant opportunities to meet customer needs and empower families to make convenient, healthy, and tasty food choices.
days to go: Expired investment: £274,197
PRESS is a health food and nutrition business specialising in Cold-Pressed juices, snacks, smoothies, soups and supplements.Our products bring healthy, delicious recipes to the hands of those customers looking to make positive decisions when it comes to what, when and how they eat and drink
days to go: Expired investment: £1,114,540
Rabble is a gamified and licensed fitness program that transforms exercise into fun, team-based games. It was first formed by a former international athlete and then financed by investors from the LA Fitness & Liverpool football club. Rabble has quickly risen to 100 authorized sites strengthening many healthy communities over the UK. It is a differentiated concept which is named as Global Fitness Trend (WGSN). It has a proven and scalable model where the market leaders earn revenue of more than $100m. Further, it has developed 100+ instructors across the UK in less than one year. Rabble aims at helping and changing more lives with the finance that it raises. It is planning to grow to more than 300 Rabble sites in the coming year.
days to go: Expired investment: £274,530
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph